Skip Navigation


Carcinogenesis Advance Access originally published online on February 12, 2006
Carcinogenesis 2006 27(8):1593-1599; doi:10.1093/carcin/bgi360
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/8/1593    most recent
bgi360v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Heikkinen, K.
Right arrow Articles by Winqvist, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heikkinen, K.
Right arrow Articles by Winqvist, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability

Katri Heikkinen1, Katrin Rapakko1, Sanna-Maria Karppinen1, Hannele Erkko1, Sakari Knuutila2, Tuija Lundán1,2, Arto Mannermaa1, Anne-Lise Børresen-Dale3, Åke Borg4, Rosa B. Barkardottir5, John Petrini6 and Robert Winqvist1,*

1 Department of Clinical Genetics, University of Oulu/Oulu University Hospital Oulu, Finland
2 Department of Pathology, Haartman Institute, University of Helsinki and HUSLAB Helsinki University Central Hospital Finland
3 Department of Genetics, Norwegian Radium Hospital Oslo, Norway
4 Department of Oncology, Lund University Hospital Lund, Sweden
5 Department of Pathology, University Hospital of Iceland Reykjavik, Iceland
6 Department of Molecular Biology, Memorial Sloan-Kettering Cancer Center New York, NY, USA

*To whom correspondence should be addressed at: Department of Clinical Genetics, Oulu University Hospital, P.O. Box 24, FIN-90029 OYS, Finland. Tel: +358 8 3153228; Fax: +358 8 3153243; Email: robert.winqvist{at}oulu.fi

The Mre11 complex, composed of RAD50, NBS1 and MRE11, has an essential role in the maintenance of genomic integrity and preventing cells from malignancy. Here we report the association of three Mre11 complex mutations with hereditary breast cancer susceptibility, studied by using a case–control design with 317 consecutive, newly diagnosed Northern Finnish breast cancer patients and 1000 geographically matched healthy controls (P = 0.0004). RAD50 687delT displayed significantly elevated frequency in the studied patients (8 out of 317, OR 4.3, 95% CI 1.5–12.5, P= 0.008), which indicates that it is a relatively common low-penetrance risk allele in this cohort. Haplotype analysis and the screening of altogether 512 additional breast cancer cases from Sweden, Norway and Iceland suggest that RAD50 687delT is a Finnish founder mutation, not present in the other Nordic cohorts. The RAD50 IVS3-1G>A splicing mutation leading to translational frameshift was observed in one patient, and the NBS1 Leu150Phe missense mutation affecting a conserved residue in the functionally important BRCA1 carboxy-terminal (BRCT) domain in two patients, both being absent from 1000 controls. Microsatellite marker analysis showed that loss of the wild-type allele was not involved in the tumorigenesis in any of the studied mutation carriers, but they all showed increased genomic instability assessed by cytogenetic analysis of peripheral blood T-lymphocytes (P = 0.006). In particular, the total number of chromosomal rearrangements was significantly increased (P = 0.002). These findings suggest an effect for RAD50 and NBS1 haploinsufficiency on genomic integrity and susceptibility to cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A. De Nicolo, M. Tancredi, G. Lombardi, C. C. Flemma, S. Barbuti, C. Di Cristofano, B. Sobhian, G. Bevilacqua, R. Drapkin, and M. A. Caligo
A Novel Breast Cancer-Associated BRIP1 (FANCJ/BACH1) Germ-line Mutation Impairs Protein Stability and Function
Clin. Cancer Res., July 15, 2008; 14(14): 4672 - 4680.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Huang, M. A. Grotzer, T. Watanabe, E. Hewer, T. Pietsch, S. Rutkowski, and H. Ohgaki
Mutations in the Nijmegen Breakage Syndrome Gene in Medulloblastomas
Clin. Cancer Res., July 1, 2008; 14(13): 4053 - 4058.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Wang, C. Szabo, C. Qian, P. G. Amadio, S. N. Thibodeau, J. R. Cerhan, G. M. Petersen, W. Liu, and F. J. Couch
Mutational Analysis of Thirty-two Double-Strand DNA Break Repair Genes in Breast and Pancreatic Cancers
Cancer Res., February 15, 2008; 68(4): 971 - 975.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H.-M. Hsu, H.-C. Wang, S.-T. Chen, G.-C. Hsu, C.-Y. Shen, and J.-C. Yu
Breast Cancer Risk Is Associated with the Genes Encoding the DNA Double-Strand Break Repair Mre11/Rad50/Nbs1 Complex
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2024 - 2032.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
S. Yoon, Y. Yang, J. Choi, and J. Seong
Large scale data mining approach for gene-specific standardization of microarray gene expression data
Bioinformatics, December 1, 2006; 22(23): 2898 - 2904.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.